drug investigational weeks study preceding treatment prior start administration participation 
investigational agent weeks treatment study prior dose administration therapy initiation 
vaccine prevention infectious therapy non oncology diseases administration ipilimumab dose 
drug study administration dose days prior weeks following therapy treatment 
cpi treatment weeks cancer initiation past investigational prior received dose 
concurrently using antineoplastic approved patient anti neoplastic investigational therapy agent 
initiation treatment study prior days weeks therapy investigational drug cancer 
medi receipt dose anticancer prior days investigational therapy amp weeks 
agent investigational registration days treatment prior therapy protocol registered study 
product investigational days medicinal prior received treatment weeks administration study 
